Adjustment of the interface detector (location 71) to the absolute number of mononuclear cells in the peripheral blood: no improvement of the collection efficiency of the Fenwal CS3000 plus during progenitor cell harvests. 1997

J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Improvement of the collection efficiency (CE) of the Fenwal CS3000 plus in collecting circulating progenitor cells (CPC) might diminish the number of leukapheresis procedures (LP) required to obtain the CPC required to assure engraftment. We analyzed whether adjustment of the optical setting (location 71,L71) to the number of MNC present in the peripheral blood could enhance the CE of the MNC. Thirty-five patients underwent 121 LP with an adjusted L71. We compared the results retrospectively with 26 LP performed with a fixed L71 (1:100) in 12 patients. The CPC were mobilized with chemotherapy followed by subcutaneous administration of granulocyte colony-stimulating factor (G-CSF) in both groups. Adjustment of the L71 did neither improve the CE of the MNC, the estimated CE of CD34+ cells nor diminished granulocyte contamination. For the total 121 LP with an adjusted L71 and for the total 26 LP with a fixed L71 the mean CE of MNC were, respectively, 44.6 +/- 18.3% and 46.4 +/- 14%. The mean granulocyte contamination, determined by manual white blood cell differentiation, was 1.7 +/- 2.3% for the adjusted L71 group and 2.3 +/- 3 for the fixed L71 group. There was no difference in the median number of LP required to obtain 3 x 10(6) CD34+ cells/kg between both groups. We found a weak significant correlation between WBC and pre-LP MNC count and the CE of MNC (r = 0.36, P = 0.012, resp.r = 0.33, P = 0.023), but no correlation between the CE of MNC and the estimated CE of CD34+ cells (r = 0.24, P = 0.113). In conclusion, adjustment of the L71 to the MNC did not improve the CE of MNC of the Fenwal CS3000. The lack of correlation between the CE and MNC and the estimated CE of CD34+ cells should be further explored.

UI MeSH Term Description Entries
D007937 Leukapheresis The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. Leukocytapheresis,Leukopheresis,Lymphapheresis,Lymphocytapheresis,Leukocytopheresis,Lymphocytopheresis,Lymphopheresis,Leukaphereses,Leukocytaphereses,Leukocytophereses,Leukophereses,Lymphaphereses,Lymphocytaphereses,Lymphocytophereses,Lymphophereses
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018952 Antigens, CD34 Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow. CD34 Antigens,CD34 Antigen,Antigen, CD34

Related Publications

J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
February 1998, Journal of hematotherapy,
J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
January 1990, Progress in clinical and biological research,
J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
January 1990, Progress in clinical and biological research,
J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
January 1991, Journal of clinical apheresis,
J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
January 1992, Journal of clinical apheresis,
J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
March 1995, Transfusion science,
J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
January 1995, Journal of clinical apheresis,
J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
January 1994, Journal of clinical apheresis,
J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
February 1994, Bone marrow transplantation,
J W Baars, and W J Nooyen, and C van Beers, and M J Holtkamp, and A te Velde, and O Daleslo, and I C Slaper-Cortenbach, and C E van der Schoot, and K Casteleyn
April 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
Copied contents to your clipboard!